Style | Citing Format |
---|---|
MLA | Dehghanighobadi Z, et al.. "Wnt5a and Tgfβ1 Converges Through Yap1 Activity and Integrin Alpha V Up-Regulation Promoting Epithelial to Mesenchymal Transition in Ovarian Cancer Cells and Mesothelial Cell Activation." Cells, vol. 11, no. 2, 2022, pp. -. |
APA | Dehghanighobadi Z, Hasani SS, Arefian E, Hossein G (2022). Wnt5a and Tgfβ1 Converges Through Yap1 Activity and Integrin Alpha V Up-Regulation Promoting Epithelial to Mesenchymal Transition in Ovarian Cancer Cells and Mesothelial Cell Activation. Cells, 11(2), -. |
Chicago | Dehghanighobadi Z, Hasani SS, Arefian E, Hossein G. "Wnt5a and Tgfβ1 Converges Through Yap1 Activity and Integrin Alpha V Up-Regulation Promoting Epithelial to Mesenchymal Transition in Ovarian Cancer Cells and Mesothelial Cell Activation." Cells 11, no. 2 (2022): -. |
Harvard | Dehghanighobadi Z et al. (2022) 'Wnt5a and Tgfβ1 Converges Through Yap1 Activity and Integrin Alpha V Up-Regulation Promoting Epithelial to Mesenchymal Transition in Ovarian Cancer Cells and Mesothelial Cell Activation', Cells, 11(2), pp. -. |
Vancouver | Dehghanighobadi Z, Hasani SS, Arefian E, Hossein G. Wnt5a and Tgfβ1 Converges Through Yap1 Activity and Integrin Alpha V Up-Regulation Promoting Epithelial to Mesenchymal Transition in Ovarian Cancer Cells and Mesothelial Cell Activation. Cells. 2022;11(2):-. |
BibTex | @article{ author = {Dehghanighobadi Z and Hasani SS and Arefian E and Hossein G}, title = {Wnt5a and Tgfβ1 Converges Through Yap1 Activity and Integrin Alpha V Up-Regulation Promoting Epithelial to Mesenchymal Transition in Ovarian Cancer Cells and Mesothelial Cell Activation}, journal = {Cells}, volume = {11}, number = {2}, pages = {-}, year = {2022} } |
RIS | TY - JOUR AU - Dehghanighobadi Z AU - Hasani SS AU - Arefian E AU - Hossein G TI - Wnt5a and Tgfβ1 Converges Through Yap1 Activity and Integrin Alpha V Up-Regulation Promoting Epithelial to Mesenchymal Transition in Ovarian Cancer Cells and Mesothelial Cell Activation JO - Cells VL - 11 IS - 2 SP - EP - PY - 2022 ER - |